Thymic remodeling associated with hyperplasia in myasthenia gravis. - Wikidata - awgldk - TriplyDB

Thymic remodeling associated with hyperplasia in myasthenia gravis.

Thymic remodeling associated with hyperplasia in myasthenia gravis.

http://www.wikidata.org/entity/Q37733580

about

Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker.Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis.Thymic epithelial cell development and its dysfunction in human diseases.The auto-antigen repertoire in myasthenia gravis.Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.Thymus pathology observed in the MGTX trial.The role of T regulatory cells in immunopathogenesis of myasthenia gravis: implications for therapeutics.Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.B-cell-activating factor and autoimmune myasthenia gravis.Pathological Findings in Myasthenia Gravis Patients with Thymic Hyperplasia and Thymoma.Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis.Lack of Epstein-Barr virus infection in Chinese myasthenia gravis patients.Lack of evidence for Epstein-Barr virus infection in myasthenia gravis thymus.Development of humanized scFv antibody fragment(s) that targets and blocks specific HLA alleles linked to myasthenia gravis.High frequencies of circulating Tfh-Th17 cells in myasthenia gravis patients.Insights in the autoimmunity of myasthenia gravis.Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls.

P2860

Q34085747-4645D070-553F-44A9-9C48-12020DEF4DC0 Q34393904-8A797B04-7095-4870-BBE5-8F44E0659D8C Q36946564-1A6A2D6A-9FE6-4B4E-AAAD-5D3B4A5A6725 Q37593760-1FE2AF2A-72E0-444B-8AF8-DAD9DA4AA2C9 Q37727984-AB7E6790-AA9F-493A-AB88-EB29EFBA091D Q37727994-69BE1349-E387-497C-AF34-AA9AFD1A4C35 Q38070759-05968643-67AA-4A22-8248-34B483D72AF4 Q38479391-8B230537-D8DF-4D86-99E6-AF0E3E8D7C80 Q38840238-8129908C-EEF2-40EB-957E-4FE3A8FB06FC Q40179681-20CCC0F7-8E23-4711-9F2E-A3C48D8510CC Q40292065-E0B7A4F9-24A3-4F65-B9A2-D5E2E9CD7646 Q44316843-82118D27-C03E-403F-B28A-F8519031948A Q45351267-2BA15BE2-4C42-44FB-926C-03D77C103ACC Q45363494-704F4B82-BD8E-4192-9FFF-B600D1436AAE Q47442517-D39D3422-41A3-43C7-B3E9-02C64C5DACF6 Q48332457-6ED96F64-1D6A-47EA-B955-FE090D8F3286 Q51853050-13151026-118D-417E-8747-89E72E1DDD59 Q52962026-020C3370-C687-4E25-8097-2D2474E49D97

P2860

Thymic remodeling associated with hyperplasia in myasthenia gravis.

http://www.wikidata.org/entity/Q37733580

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Thymic remodeling associated with hyperplasia in myasthenia gravis.

@en

Thymic remodeling associated with hyperplasia in myasthenia gravis.

@nl

type

label

Thymic remodeling associated with hyperplasia in myasthenia gravis.

@en

Thymic remodeling associated with hyperplasia in myasthenia gravis.

@nl

prefLabel

Thymic remodeling associated with hyperplasia in myasthenia gravis.

@en

Thymic remodeling associated with hyperplasia in myasthenia gravis.

@nl

P1433

Q37733580-233F775C-39B1-4C16-AFF1-D5EABFFDE32E

P1476

Q37733580-B96409EB-B60A-4A31-8CCE-96916D0D4B09

P2093

Q37733580-08CA9AFA-6915-4BD3-BFEA-D306974CA63D

Q37733580-1AF4BCF5-A888-4A58-BBFE-83953ECF263E

Q37733580-708B5289-4EB2-46C7-AE9A-802D66A4448D

Q37733580-863364C9-B666-432F-81B0-24EDC7F160D2

Q37733580-F7FA40F0-427C-4465-BA64-ECAA3801AC46

Q37733580-FF04DE08-8757-4BE2-915C-502B029A739F

P2860

Q37733580-059CB504-A90D-4B80-925C-DC365C484F97

Q37733580-097C1683-DE6E-4392-A136-B2D906DF4D4F

Q37733580-09BEE2CA-CDEE-497C-84BE-F3A3FF390057

Q37733580-0E67FF19-D115-42A2-B69A-D64E61FAD1A1

Q37733580-111E2082-192D-48DD-AD53-3ADABBE78A44

Q37733580-125288AF-83BA-4A21-AC39-19572AAF6185

Q37733580-12B14DEF-74AA-4D3A-8BF7-D6981EA07917

Q37733580-134129D6-A89F-4AAF-939C-ED4931C60F75

Q37733580-14E35A59-571E-42AE-8A09-839CC94931AF

Q37733580-1BA656EC-1F4F-4273-9059-91855799C4ED

P304

Q37733580-D251CA4A-9CEE-495E-92DB-07F406A50EB8

P31

Q37733580-F024A803-2C52-4459-A5EF-51B3D0E6D92B

P356

Q37733580-9B42AAA3-C1B2-48F3-9FBA-C0973336E749

P433

Q37733580-CBC61A96-A389-4CE5-8410-44A64B0D545B

P478

Q37733580-189D467D-C181-461F-BB00-CAF889CAE2A4

P50

Q37733580-86A6C791-389D-4B67-BF9D-8E1E3D3C4678

Q37733580-F3EDCBE9-D809-4DB2-B0C6-B251B5AA122F

P577

Q37733580-E4C3A8F1-9CB8-4A7C-A90B-0D7018C91FDA

P698

Q37733580-7C01AE68-C2F0-4EE1-BA22-097D52D5019F

P921

Q37733580-6F3C2606-3895-4C58-A41A-4833C56271F2

P356

08916930903563491

P1433

P1476

Thymic remodeling associated with hyperplasia in myasthenia gravis.

@en

P2093

Géraldine Cizeron-Clairac

http://www.w3.org/2001/XMLSchema#string

Jacky Bismuth

http://www.w3.org/2001/XMLSchema#string

Julia Miriam Weiss

http://www.w3.org/2001/XMLSchema#string

Nicole Kerlero De Rosbo

http://www.w3.org/2001/XMLSchema#string

Perrine Cufi

http://www.w3.org/2001/XMLSchema#string

Philippe Dartevelle

http://www.w3.org/2001/XMLSchema#string

P2860

The thymus is a common target organ in infectious diseases

Macrophage-derived chemokine and EBI1-ligand chemokine attract human thymocytes in different stage of development and are produced by distinct subsets of medullary epithelial cells: possible implications for negative selection

The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis

B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5

Thymic hyperplasia in patients with Graves' disease. Identification of thyrotropin receptors in human thymus

Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus

IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis

A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes

The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors

A high endothelial venule secretory protein, mac25/angiomodulin, interacts with multiple high endothelial venule-associated molecules including chemokines

P304

401-412

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/08916930903563491

http://www.w3.org/2001/XMLSchema#string

P433

5-6

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

Sonia Berrih-Aknin

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20402580

http://www.w3.org/2001/XMLSchema#string

P921

myasthenia gravis